Tagged: biomed

April 12, 2017 @ 7:57 am By JD Alois  |  

Biotech company Celixir has initiated a share-back for early investors. The company is offering shareholders a 2.7x return if they accept the offer. According to the company, 18% of Celixir shareholders have decided to accept the offer with the remaining holding their shares with the… Read More

October 28, 2013 @ 9:49 am By Charles Luzar  |  

Cambridge-based stem cell research tool provider Cell Guidance Systems has successfully crowdfunded over £242,000 on equity crowdfunding platform Crowdcube. The raise represents a £2,000,000 valuation. The funds come for a 12.14% equity stake dispersed among the crowd. CGS was originally seeking $100,000 in funding for… Read More

September 26, 2013 @ 10:23 pm By JD Alois  |  

Perle Bioscience wants to cure diabetes and they need to raise capital to accomplish their goal.  They chose BlazeFund because they specialize in life-sciences and are making a paradigm shift in accessing capital. The statistics on the impact of Type 1 Diabetes is compelling: 26 million patients…. Read More